NCT05949424 2023-11-29
OPTI-DOSE
University Medical Center Groningen
Phase 4 Unknown
Clinical Trials
11 trialsNCT04741438 2023-08-30
RAR-Immune
Centre Leon Berard
Phase 3 Unknown
NCT05816642 2023-04-18
Application Circulating Tumor DNA Dynamic Monitoring in Clinical Treatment of Metastatic Renal Cell Carcinoma
RenJi Hospital
Phase NA Unknown
NCT02638428 2020-03-19
Genomics-Based Target Therapy for Children With Relapsed or Refractory Malignancy
Samsung Medical Center
Phase 2 Unknown
NCT03571438 2020-01-18
COMBOREIN
University Hospital, Grenoble
Phase NA Unknown
NCT03628131 2018-09-19
Combination Chemotherapy With Pazopanib in Children and Adolescents With Relapsed/Refractory Solid Tumors
Samsung Medical Center
Phase 1/2 Unknown
NCT01600573 2016-10-11
Pazopanib and Weekly Topotecan in Patients Recurrent Ovarian Cancer (TOPAZ)
Charite University, Berlin, Germany
Phase 1/2 Unknown
NCT02324803 2014-12-24
Phase II Study of Pazopanib as Second-line Treatment After Sunitinib in mRCC Patients
Southern China Urology Cancer Consortium
Phase 2 Unknown
NCT02208128 2014-08-04
MORE
Heidelberg University
Phase NA Unknown
NCT01577784 2014-03-12
Pazopanib in Second-line Therapy in Renal Cell Carcinoma
Associació per a la Recerca Oncologica, Spain
Phase 2 Unknown
NCT01377298 2011-06-21
Pazopanib in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
National Taiwan University Hospital
Phase 2 Unknown